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ABSTRACT: PEGylation, covalent attachment of PEG to therapeutic
biomolecules, in which suboptimal pharmacokinetic profiles limiting their
therapeutic utility are of concern, is a widely applied technology.
However, this technology has been challenged by reduced bioactivity of
biomolecules upon PEGylation and immunogenicity of PEG triggering
immune response and abrogating clinical efficacy, which collectively
necessitate development of stealth polymer alternatives. Here we
demonstrate that comb-shape poly[oligo(ethylene glycol) methyl ether
methacrylate] (POEGMA), a stealth polymer alternative, has a more
compact structure than PEG and self-organize into nanoparticles in a
molecular weight dependent manner. Most notably, we show that comb-
shape POEGMA promotes significantly higher cellular uptake and
exhibits less steric hindrance imposed on the conjugated biomolecule
than PEG. Collectively, comb-shape POEGMA offers a versatile alternative to PEG for stealth polymer−biomolecule conjugation
applications.
■ INTRODUCTION
Biomolecular therapeutics have been increasingly used in the
treatment of diseases. However, the suboptimal pharmacoki-
netic profiles of biomolecules, except antibodies, albumin, and
transferrin,1 limit their utility as therapeutic reagents.2 Covalent
attachment of polyethylene glycol (PEG) to biomolecules,
“PEGylation”, is one of the most widely used technologies to
overcome intrinsic pharmacokinetic limitations of therapeutic
biomolecules owing to its “stealth” properties.3−8 However,
PEGylation usually results in reduced bioactivity by masking
conjugated biomolecules with a hydrated polymeric cloud.9−11
In addition, the presence of anti-PEG antibodies has been
reported in the clinical trials of several PEGylated therapeutic
agents12−15 and even in PEGylated therapeutic agent-naive
individuals.16,17 Consequently, these attributes of PEG have led
the researchers to search for better stealth polymer alternatives.
Recently, a comb-shape PEG-like polymer, poly(oligo-
(ethylene glycol) methyl ether (meth)acrylate (POEG(M)A),
which consists of a number of hydrophilic PEG oligomer chains
grafted to a hydrophobic poly(meth)acrylate backbone, has
been suggested as a viable alternative to the gold standard PEG.
The comb-shape POEGMA has been reported to improve
pharmacokinetic properties of protein and peptide conju-
gates,18,19 enhance stability and gene silencing efficiency of
siRNAs,20 and, most intriguingly, eliminate PEG antigenicity.1
However, an extensive analysis on the effect of architecture on
harnessing these features remains to be investigated.
Herein, we compare comb-shape POEGMA with linear PEG
in terms of physicochemical properties (i.e., size, molecular
conformation), in vitro cell interaction profiles and steric
hindrance imposed on the conjugated biomolecules. For this
purpose, POEGMAs at two different molecular weights within
the hydrodynamic size range of renal clearance were
synthesized and characterized in terms of their molecular
conformation and hydrodynamic size in various solutions along
with their linear PEG counterparts at the same molecular
weights. The cytotoxicity profile, the effect on the cell
membrane integrity, cellular uptake profile, and cellular uptake
mechanism of POEGMAs were investigated in cancerous and
healthy cell lines and compared with those of the PEG
counterparts. Finally, to determine the possible differences in
the steric hindrance imposed by POEGMA or PEG on
biomolecules, RGD peptide conjugates of both polymers
were synthesized and compared in terms of integrin targeting
efficiencies. It is important to note, however, that this study is
of fundamental nature and does not aim to mimic in vivo
conditions in which PEG and POEGMA are utilized or to find
an eventual correlation with in vivo performances of PEG and
POEGMA conjugates.
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■ EXPERIMENTAL SECTION
Synthesis of POEGMA via RAFT Polymerization. Poly(oligo-
(ethylene glycol)) methyl ether methacrylate (POEGMA) was
synthesized according to the procedures reported elsewhere.20,21
Briefly, oligo(ethylene glycol) methyl ether methacrylate (OEGMA,
number-average molecular weight (Mn) 475 Da) monomer (4.75 g, 10
mmol), 4-cyano-4-(phenylcarbonothioylthio) pentanoic acid (0.0556
g, 0.2 mmol), and 2,2 azobis(isobutyronitrile) (8.2 mg, 0.05 mmol)
were dissolved in acetonitrile (10 mL) in a Schlenk flask and the
resulting solution was purged with nitrogen for 30 min on ice bath.
Then, polymerization was initiated by immersion of the flask into an
oil bath at 65 °C and continued for 140 or 225 min to obtain
POEGMA10K and POEGMA20K, respectively. The solvent was partially
removed under vacuum and the resulting mixture was purified via
dialysis against ultrapure water for 5 days using dialysis tubing with
molecular weight cutoff (MWCO) 3500 or cold diethyl ether
precipitation, yielding pure POEGMA10K and POEGMA20K, respec-
tively. The resulting polymers were characterized via nuclear magnetic
resonance (NMR; Figure S1) and gel permeation chromatography
(GPC; Figure 2). Table 1 shows weight-average molecular weight
(MwRALS‑GPC), number-average molecular weight (MnRALS‑GPC), and
polydispersity index (PDI: Mw/Mn) values measured by right-angle
light scattering-gel permeation chromatography (RALS-GPC) and
number-average molecular weight calculated by 1H NMR end-group
analyses (MnNMR) of polymers.
End-Group Modification of Polymers. The thiocarbonylthio
end-group of RAFT-synthesized POEGMAs was cleaved in order to
prevent possible cytotoxic effects22 via aminolysis reaction in the
presence of excess amines, following a procedure reported else-
where.23,24 Briefly, POEGMA10K or POEGMA20K (0.01 mmol),
hexylamine (HEA; 0.0133 mL, 0.1 mmol), and triethylamine (TEA;
0.0140 mL, 0.1 mmol) were dissolved in acetonitrile (2.5 mL) and the
resulting solution was kept stirred under nitrogen atmosphere for 2 h
at room temperature, yielding thiocarbonylthio end-group removed
thiol end-group functional polymers. The resulting thiol end-group
functional polymers were immediately purified via cold diethyl ether
precipitation. End-group modification of the polymers was verified by
1H NMR spectroscopy (Figure S2).
Prior to toxicity assays, thiol end-group of RAFT-synthesized
POEGMAs formed after aminolysis and linear PEGs (mPEG-SH)
were stably capped by addition of an oligo(ethylene glycol) methyl
ether acrylate unit following a protocol reported elsewhere.23 After
end-group capping, the resulting polymers were purified via dialysis
against ultrapure water for 5 days using dialysis tubing with MWCO
3500.
Prior to in vitro cell uptake experiments, thiol end-group of both
linear PEGs (mPEG10K/20K-SH and NH2-PEG10K-SH) and comb-shape
POEGMAs was labeled with Oregon Green maleimide 488 or Cy3-
maleimide fluorescent dye. Briefly, thiol-ended polymer (100 mM)
and TCEP (4 M) were dissolved in phosphate buffer (0.2 M, pH 7.4)
to reduce possible disulfide bonds. Then, Oregon Green maleimide
488 or Cy3 maleimide fluorescent dye was added to the reduced
polymer solution under stirring yielding a solution in which polymer
and dye concentrations were 40 and 200 mM, respectively. The
resulting solution was purged with nitrogen for 30 min and stirred for
2 h at room temperature followed by addition of fresh TCEP (0.4 M)
under nitrogen and overnight reaction. The resulting dye−polymer
conjugate was purified via dialysis using MWCO 3500 dialysis tubing
against ultrapure water for 5 days and then freeze-dried. The absence
of unconjugated dye in the fluorescent dye conjugated polymer
solution was confirmed by size exclusion chromatography (SEC). The
Oregon Green 488 or Cy3 fluorescent dye conjugation to the
polymers was then confirmed via UV−vis spectroscopy analyses
(Figure S4) and the degree of conjugation was calculated according to
the manufacturers’ protocols (Molecular Probes, Oregon, U.S.A.) that
follow Beer−Lambert Law (Ax = εxxbxC), where A is the absorbance
at 501 nm or at 555 nm for Oregon Green 488 or Cy3, respectively, ε
is the extinction coefficient (81000 M−1 cm−1 for Oregon Green 488 at
501 nm, or 150000 M−1 cm−1 for Cy3 at 555 nm (provided by
manufacturers)), b is the path length (cm), C is the concentration
(M), and x is the specific wavelength (501 nm for Oregon Green 488
or 555 nm for Cy3). The degree of Oregon Green 488 or Cy3
fluorescent dye conjugation to polymers were given in Tables S1 and
S2.
The resulting Oregon Green 488 fluorescent dye conjugated
polymers were utilized in experiments to determine energy-dependent
cellular uptake of polymers, time- and dose-dependent cellular uptake
of polymers, the effect of cytoskeleton components on the cellular
uptake polymers, and endocytosis routes mediating cellular uptake of
polymers as described below. The resulting Cy3 fluorescent dye
conjugated polymers were utilized in RGD (cRGDyC) conjugation
experiments as described below.
cRGDyC Conjugation. ω-Fluorescent (Cy3) labeled POEGMA10K
(Mn 9975 Da; 15.4 mg, 3 mM), N-(3-(dimethylamino)propyl)-N-
ethylcarbodiimide hydrochloride (EDC; 1.48 mg, 15 mM) and N-
hydroxysuccinimide (NHS; 1.78 mg, 30 mM) were dissolved in
phosphate buffer (0.51 mL, 0.2 M, pH 5.5) and reacted for 15 min.
Then, ethylenediamine (5.2 μL, 150 mM) was added to the polymer
solution in which the final pH was adjusted to 7.8. The resulting
solution was reacted at room temperature for 4 h and then dialyzed
against ultrapure water for 3 days using MWCO 3500 dialysis tubing
followed by freeze-drying to obtain α-amine-terminated, ω-Cy3
fluorescent-labeled POEGMA10K.
In the next step, α-amine-terminated ω-Cy3 fluorescent-labeled
POEGMA10K or linear PEG10K was reacted with N-γ-maleimidobu-
tyryl-oxysuccinimide ester (GMBS) cross-linker bearing NHS-ester
and maleimide end groups to yield α-maleimide functional polymer
chains. To do so, the cross-linker (4.2 mg, 40 mM) was dissolved in
phosphate buffer (0.5 M, pH 7.2) and reacted with amine-terminated
linear PEG10K or POEGMA10K (15 mg, 4 mM) for 45 min. The
unreacted GMBS was removed via desalting (Pierce Polyacrylamide
Desalting Columns, 1.8K MWCO) using phosphate buffer at pH 5.5
as mobile phase, yielding pure α-maleimide functional polymers, which
were then freeze-dried.
The resulting α-maleimide terminated polymers (14.5 mg, 1 mM)
were dissolved in phosphate buffer (0.5 M, pH 7.2) containing
cRGDyC peptide (8.3 mg, 10 mM) and TCEP (4.3 mg, 10 mM). The
resulting solution was purged with nitrogen for 30 min and stirred for
2 h, followed by the addition of fresh TCEP (2.15 mg, 5 mM) under a
nitrogen atmosphere. The reaction was continued overnight, and the
resulting polymer−peptide conjugate was purified via dialysis against
ultrapure water for 5 days using MWCO 3500 membrane and then
freeze-dried.
RGD conjugations to Cy3-labeled POEGMA10K and PEG10K were
verified via UV−vis spectroscopy analyses (Figure 9) using well-
established methods in the literature. Prior to UV−vis spectroscopy
analyses, the absence of unconjugated RGD in the RGD-POEGMA10K-
Cy3 and RGD-PEG10K-Cy3 polymer solutions was confirmed by SEC.
Then, the RGD conjugation degree was calculated relative to the
degree of Cy3 fluorescent dye labeling by following Beer−Lambert
Law (Ax = εxxbxC), where A is the corrected absorbance deriving from
the RGD moiety on the polymer at 280 nm (free from signal
interference of Cy3-labeled polymer at 280 nm), ε is the extinction
coefficient of RGD (1280 M−1 cm−1 for cRGDyC (provided by the
manufacturer), b is the path length (cm), C is the concentration (M),
and x is the specific wavelength (280 nm for RGD due to signal of
Table 1. Physical Properties of POEGMAs Used in the
Studya
polymer
MwRALS‑GPC
(Da)
MnRALS‑GPC
(Da) PDIRALS‑GPC
MNMR
(Da)
POEGMA10K 9700 8860 1.12 8470
POEGMA20K 20300 17200 1.18 16100
aProperties of linear counterparts, PEGs, were determined from their
manufacturers: PEG10K (Mn 10 kDa, PDI < 1.08) and PEG20K (Mn 20
kDa, PDI < 1.08).
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tyrosine at 280 nm). Finally, using the known Cy3 fluorescent labeling
degree of the polymers given above, the RGD conjugation degree was
calculated according to eq 1. Table S2 shows RGD conjugation
degrees of RGD-POEGMA10K-Cy3 and RGD-PEG10K-Cy3, which
were further utilized in experiments to determine the effect of
POEGMA and PEG on the integrin targeting efficiency of RGD
conjugates as described below.
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Cell Culture Methods. BEAS-2B and A549 cells were cultured
using DMEM and RPMI-1640 medium, respectively, supplemented
with 10% fetal bovine serum (FBS) and 0.1% gentamicin at 37 °C in a
humidified 5% CO2 atmosphere. Subculture was performed when the
cells had 80−90% confluence using trypsin-EDTA. The experimental
details of cell viability and membrane integrity experiments were given
in SI.
Cell Uptake of Polymers. Energy-dependent cell uptake of
Oregon Green 488 labeled polymers, time- and dose-dependent
cellular uptake of Oregon Green 488 labeled polymers, the effect of
cytoskeleton components on the cellular uptake of Oregon Green 488
labeled polymers, endocytosis routes mediating cellular uptake of
Oregon Green 488 labeled POEGMAs and PEGs, the effect of
POEGMA and PEG on the integrin targeting efficiency of RGD-
POEGMA10K-Cy3 and RGD-PEG10K-Cy3 were determined via flow
cytometry analyses. Briefly, A549 and BEAS-2B cells were transferred
to 12-well plates at a concentration of 105 cells per well a day prior to
sample exposure and incubated overnight at 37 °C in a humidified 5%
CO2 atmosphere. Fluorescent dye-labeled polymer stock solution (5
mM) was prepared in PBS (1×) and filtered through a prerinsed 0.22
μm syringe filter. The cellular uptake of polymers was investigated via
incubating the cells with polymers at specified temperatures for
specified durations. At the end of the incubation period, the cell
culture medium was removed immediately and wells were washed with
cold PBS twice on ice. The cells were then harvested by trypsinization
and centrifuged for 5 min at 4 °C. The supernatant was removed and
the resulting pellet was resuspended in cold PBS (200 μL). The
cellular uptake of polymers was measured via flow cytometry (BD
FACSCantoTM, BD Biosciences, San Jose, U.S.A.), equipped with
Oregon Green solid state 488 laser and 530/30 filter configuration.
Data from 10000 events per sample were collected and analyzed using
FacsDiva software. % Cellular uptake (i.e., the ratio of the number of
cells that internalize the polymer to the total number of cells) and
uptake intensity (i.e., total fluorescence intensity divided by the total
number of cells) determined from flow cytometry data and then were
normalized according to the fluorescent dye labeling degree of
polymers.
Energy-Dependent Cell Uptake of Polymers. The energy
dependency of cellular uptake was investigated via incubating the cells
with Oregon Green 488 labeled polymers at either 4 or 37 °C. For this
purpose, first, cell suspensions and polymer solutions were separately
incubated at either 4 or 37 °C for 1 h prior to the addition of polymers
to cells to equilibrate the temperature. After the equilibration period,
the polymer solutions were added into the wells preserving the
temperature of solutions at specified values. The final polymer
concentration was 25 μM. The final PBS content was lower than or
equal to 0.5% (v/v). The cells were incubated with polymers at
specified temperatures for 1 or 3 h. At the end of the incubation
period, the flow cytometry procedure given above was followed.
Time- and Dose-Dependent Cellular Uptake of Polymers.
The time- and dose- dependency of cell uptake of Oregon Green 488
labeled polymers were investigated via incubating the cells with
polymers at varying concentrations (12.5 or 25 μM) for 1 or 3 h at 37
°C in a humidified 5% CO2 atmosphere. The final PBS content was
lower than or equal to 0.5% (v/v). At the end of the incubation period,
the flow cytometry procedure given above was followed.
Effect of Cytoskeleton Components on the Cellular Uptake
of Polymers. To gain better understanding of uptake mechanism of
polymers, cellular uptake experiments were performed in the presence
of cytoskeleton inhibitors, which are nocodazole (Noc) and
cytochalasin D (CytD). First, the noncytotoxic dose range of inhibitors
was determined based on the results of cell viability and membrane
integrity assays in which cells were incubated with varying
concentrations of inhibitors without any polymers for 2 h. No
significant change in the membrane integrity was observed in the
inhibitor concentration range studied (data not shown). Based on the
cell viability results (Figure S7), the working concentration of Noc and
CytD was determined to be 20 and 10 μM in both cell lines,
respectively.
After determining noncytotoxic dose range of inhibitors, Oregon
Green 488 labeled polymer uptake profiles of cells in the presence of
inhibitors were determined. For this purpose, on the day of analysis,
the cells were first treated with the inhibitor(s) for 1 h prior to
polymer addition to promote cytoskeleton inhibition. The polymer
solution was then added into the wells followed by 1 h incubation at
37 °C. The final polymer concentration was 12.5 μM. Note that the
inhibitor concentration remained constant after polymer addition. The
final PBS content was equal to or lower than 0.5% (v/v). At the end of
the incubation period, the flow cytometry procedure given above was
followed.
Endocytosis Routes Mediating Cellular Uptake of POEGMAs
and PEGs. To gain better understanding of the uptake mechanism of
POEGMAs and PEGs, CDE and CME pathways were inhibited in the
presence of chlorpromazine (CPZ) and genistein (GEN), respectively.
First, the noncytotoxic dose ranges of inhibitors were determined via
cell viability and membrane integrity assays in which cells were
incubated with varying concentrations of inhibitors without any
polymers for 2 h. The cell viability was found to be above 50% (Figure
S8) and no significant change in the membrane integrity was observed
in the inhibitor concentration range studied (data not shown).
After determining noncytotoxic dose range of inhibitors, the
noncytotoxic minimum dose required to inhibit the specific
endocytosis route was determined based on the uptake profile of
pathway-specific marker molecules in the presence of inhibitors. To do
so, A549 and BEAS-2B cells were incubated at various concentrations
of CPZ and GEN within the noncytotoxic dose range for 1 h at 37 °C
in a humidified atmosphere followed by addition of pathway-specific
marker molecules, which were transferrin from human serum (hTf)
AlexaFluor 647 conjugate (2 μg mL−1) or BODIPY FL C5-
lactosylceramide complexed to BSA (1 μM), respectively, and
incubation for an additional hour. hTf is known to be specifically
internalized via the CDE pathway, thus considered to be one of the
markers of the CDE pathway.25,26 Lactosylceramide, on the other
hand, a glycosphingolipid that resides in lipid rafts, is considered to be
one of the best-characterized cargo molecules of the CME pathway
and its cellular uptake is reported to be a direct evidence of the
presence of caveola.25,26 At the end of the incubation period, the flow
cytometry procedure given above was followed to determine the
inhibition efficiencies of CDE and CME pathways. The uptake profile
of pathway-specific marker molecules was shown in Figure S9 and
inhibition efficiencies of CDE and CME pathways were given in Table
S3. Overall, the optimum dose of CPZ and GEN was determined to be
100 μM and 2 mM for both cell lines, respectively.
To investigate the role of macropinocytosis, which is a subtype of
endocytosis, on mediating the uptake of polymers, the working
concentration range of 5-(N-ethyl-N-isopropyl) amiloride (EIPA),
which inhibits macropinocytosis by lowering the submembranous pH,
was determined by following the protocol described above at the EIPA
concentration range of 0−200 μM (Figure S10a). FITC-dextran (70
kDa) was used as pathway-specific marker, which is known to be
internalized only via macropinocytosis due to its large hydrodynamic
size, at a concentration of 3 mg/mL to determine inhibition profile of
macropinocytosis at known concentrations of EIPA (Figure S10b).27
After determining the working concentration of CPZ and GEN, the
cellular uptake profiles of Oregon Green 488 labeled POEGMAs and
PEGs were determined in the presence of given concentrations of
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inhibitors. To do so, on the day of analysis, the cells were first treated
with the inhibitor(s) for 1 h prior to polymer addition to promote
endocytosis inhibition. The polymer solution was then added into the
wells followed by a 1 h incubation at 37 °C. The final polymer
concentration was 12.5 μM. Note that the inhibitor concentration
remained constant after polymer addition. The final PBS content was
equal to or lower than 0.5%(v/v). At the end of the incubation period,
the flow cytometry procedure given above was followed.
Effect of POEGMA and PEG on the Integrin Targeting
Efficiency of RGD Conjugates. The steric hindrance imposed on
the integrin-targeting RGD moiety by POEGMA and PEG was
compared. To do so, A549 and BEAS-2B cells, which are both known
to express a wide range of integrin receptors on their surface28,29 were
used for determining the effect of polymer architecture on integrin
targeting efficiency of RGD. To do so, on the day of analysis, the cells
were incubated in the presence of 25 μM RGD-POEGMA10K-Cy3
(RGD-POEGMA), RGD-PEG10K-Cy3 (RGD-PEG), and only Cy3-
labeled POEGMA or PEG (without RGD) for 1 h at 37 °C, followed
by flow cytometry analyses, as described above.
Analytical Techniques and Physicochemical Characteriza-
tion Methods. Gel Permeation Chromatography. A Malvern
BIYOM Viscotek gel permeation chromatography system equipped
with a triple detector array, which consists of integrated refractive
index, viscometer and right-angle light scattering detectors, and TSK
Gel G3000PWXL column was used to characterize molecular weight
(Mw and Mn) and molecular weight distribution (PDI) of polymers.
POEGMA samples were dissolved in ultrapure water at 2 mg mL−1
concentration and filtered through a prerinsed 0.1 μm syringe filter.
The injection volume was 100 μL. PBS (0.02 M sodium phosphate,
0.15 M NaCl, 0.05% NaN3) was used as mobile phase at a flow rate of
0.8 mL min−1. The calibration was performed using poly(ethylene
oxide) (PEO) standards provided by Malvern.
UV−Vis Spectroscopy. A Thermo Scientific Evolution 201 UV−vis
spectrophotometer was used to determine the fluorescent dye
attachment to polymers at scanning mode in the range between 350
and 600 nm using quartz cuvettes. A Varioskan Flash microplate
reader (Thermo Electron Corporation, Finland) was used to measure
the absorbance values in a 96-well-plate in MTT and LDH assays.
NMR Spectroscopy. NMR spectroscopy was used to determine the
chemical structure, purity and molecular weight (MnNMR) of the
synthesized polymers. 1H NMR spectra were recorded on a Varian
VNMRJ 400 spectrometer at Izmir Institute of Technology, Izmir. For
NMR analyses, polymer samples were dissolved in deuterated
chloroform (CDCl3) or deuterium oxide (D2O) at 10 mg mL
−1
concentration. ACD/SpecManager software was used to analyze NMR
spectra.
Dynamic Light Scattering (DLS). The hydrodynamic diameter (Dh)
of polymers was measured via dynamic light scattering (DLS) analysis.
The Dh of comb-shape POEGMAs was analyzed after aminolysis and
stably capping of the resulting thiol end-group by addition of an
oligo(ethylene glycol) methyl ether acrylate unit. Similarly, the Dh of
linear PEGs was measured after capping of the thiol end-group by
following the same procedure. PEG and POEGMA solutions (0.05
mM) were prepared in prefiltered ultrapure water, 1× phosphate
buffer (pH 7.2) or phenol red-free cell culture medium with or without
10% serum. The resulting solutions were filtered through a prerinsed
0.1 μm syringe filter immediately before DLS analyses. In order to
prevent the interfering effect of serum proteins, polymers to be
analyzed were incubated in serum containing phenol red-free cell
culture medium or PBS overnight (1 M) and diluted into water (0.05
M) followed by filtering through a prerinsed 0.1 μm syringe filter just
before the DLS analysis. The Dh of the polymers was measured using
Zetasizer Nano ZS (Malvern, U.K.; measurement range 0.3 nm to 10.0
μm; light source He−Ne laser 633 nm Max 5 mW; Power 100 VA)
and Malvern disposable polystyrene low volume cuvettes at room
temperature.
Atomic Force Microscopy (AFM). Linear PEGs or comb-shape
POEGMAs, which were capped with an oligo(ethylene glycol) methyl
ether acrylate unit through their thiol end-groups were dissolved in
ultrapure water. Nanosurf EasyScan (Felx AFM) atomic force
microscope operating in tapping mode in liquid was used to obtain
topographic data. All imaging operations were conducted with 512 ×
512 data acquisitions at a various scan speed. NCLR tips with
integrated cantilever having a nominal spring constant of 48 N/m were
used. For experiments, Si (111) substrates were used after cleaning
with Piranha (CAUTION) solution. In a typical experiment, Si(111)
substrate in ultrapure water was first scanned and then polymer
solution (1 μM in ultrapure water) was applied, followed by a waiting
period of approximately 30 min. A scan of approximately the same area
was then performed. Images were manipulated using the scanning
probe image processor (SPIP) software. Contrast-enhanced images
were obtained by applying a correlation averaging procedure to
analyze repeating molecular units and by applying low-pass filter.
Surface Plasmon Resonance (SPR). SPR Navi 200 system from
BioNavis (Finland) with multiflow cells was used for SPR analyses.
Gold sensor slides used in the system were purchased from BioNavis
(Finland) and stored under nitrogen. Prior to use, the gold sensor
slides were cleaned by immersing into a solution of sulfuric acid and
hydrogen peroxide (3:1) for up to 1 min. The slides were then rinsed
thoroughly with pure water and absolute ethanol followed by rapid
drying with nitrogen stream. The SPR analyses were carried out at a
flow rate of 10 μL/min for 10 min using thiol-ended PEG10K or
POEGMA10K (0.05 mM) and 20% FBS solutions.
Statistical Analysis. Two-way analysis of variance (ANOVA)
followed by post hoc Dunnett’s multiple comparison test was
employed for the statistical analysis of the obtained data and p <
0.05 or p < 0.01 values were considered to be statistically significant.
The results of experiments, which were performed at least twice with
at least three repeats, were expressed as mean ± standard deviation.
■ RESULTS AND DISCUSSION
Considering the common use of linear PEGs having molecular
weights in the range of 5−20 kDa allowing renal clearance in
therapeutic formulations, POEGMAs within this weight-
average molecular weight (Mw) range with low polydispersity
(PDI) were synthesized via RAFT polymerization (POEG-
MA10K; Mw 9.7 kDa, PDI 1.12 and POEGMA20K; Mw 20.3 kDa,
PDI 1.18; Figures 1, 2, and S1 and Table 1). The linear
counterparts of the polymers were obtained commercially (Mn
10 kDa, PDI < 1.08 (PEG10K); Mn 20 kDa, PDI < 1.08
(PEG20K)).
Since the hydrodynamic size of polymers is one of the most
important parameters determining their interactions with
biological systems and in vivo fate,30,31 the number-average
hydrodynamic diameter (Dh) of POEGMA and PEG in various
media (water, phosphate buffer saline (PBS), and cell culture
media with or without serum) at room temperature was
investigated via dynamic light scattering (DLS) experiments
(Figure 3). The Dh of POEGMA (2.84 ± 1.20 nm,
POEGMA10K; 4.22 ± 0.41 nm, POEGMA20K) was found to
be significantly (p < 0.05) smaller than that of PEG (6.69 ±
1.07 nm, PEG10K; 8.46 ± 0.41 nm, PEG20K) at equivalent
molecular weight (MW) when water was used. This is expected
since the branched structure of POEGMA has more compact
Figure 1. Synthesis of POEGMA. [Monomer]/[chain transfer agent]/
[initiator] = 200:4:1, acetonitrile, 65 °C, 140 min (POEGMA10K), and
225 min (POEGMA20K).
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conformation compared with the linear architecture. The Dh
measurements of PEG chains were found to be in good
agreement with literature values.32 It has been known that the
MW of the polymers has a significant effect on Dh; however, the
MW did not seem to have any significant effect on the Dh of the
polymers used in this study in the range studied (p > 0.05). In
other words, the Dh of the polymers used in the study did not
show any statistical difference in the MW range studied. In the
case of PBS and cell culture media without serum, for both
architectures and MW, no significant change in Dh occurred
compared to those in water. It is expected that the presence of
salts and charged compounds would not affect PEG or
POEGMA chain conformation in solutions as both polymers
have nonionizable and neutral chemical structure. It is
important to note, however, that POEGMA shows temper-
ature-responsive behavior and phase transitions above its lower
critical solution temperature (LCST), and can be salted-out at
high salt concentrations due to partial dehydration of the
macromolecules.33,34 However, the effects observed in this
study cannot be attributed to the phase-transition or salting-out
of POEGMA. First, LCST of POEGMA with 8−9 ethylene
glycol repeating units (Mw: 16800 g/mol), which very closely
resembles to the polymers used in this study, was estimated to
be around 100 °C in PBS, which was well above room
temperature.33 Second, the salt concentration used in this study
(8 g/L) was lower than the salt concentration needed to salt-
out even a more hydrophobic form of POEGMA, a
P(MEO2MA-co-OEGMA) copolymer, which is more than 12
g/L at room temperature.34
On the other hand, the Dh of POEGMAs increased
significantly (p < 0.05) when PBS or cell culture media
containing 10% serum was used as a solvent, while there was no
significant change in the Dh of PEGs revealing that comb-shape
POEGMA differs significantly from PEG in terms of protein-
repellent properties (Figure 3). This result may be attributed to
the existence of hydrophobic interactions between serum
protein components and poly(methacrylate) backbone of
comb-shape POEGMA.
To further investigate the interaction between comb-shape
POEGMA and serum components, and to compare with that of
linear PEG, SPR spectroscopy was used (Figure 4). For this
purpose, thiol-terminated PEG10K or POEGMA10K solutions
(0.05 mM) were injected to the SPR cell at a flow rate of 10
μL/min for 10 min. First injection of polymer solutions caused
Figure 2. GPC chromatogram of POEGMA10K and POEGMA20K.
Figure 3. Hydrodynamic diameter (Dh) of comb-shape POEGMAs
and linear PEGs (nm) (PBS: phosphate buffer saline, PBS-S: PBS
containing 10% serum, CCM: cell culture medium, CCM-S: CCM
containing 10% serum). Data were analyzed by two-way ANOVA
followed by post hoc Dunnett’s multiple comparison test and plotted
as mean ± standard deviation, n = 12; *p < 0.05.
Figure 4. Surface plasmon resonance (SPR) spectroscopy analysis of the interaction of serum components with PEG10K (a) and POEGMA10K (b).
P1−6 and P1−3 are polymer solution injections and S1−3 are 20% FBS solution injections.
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a sharp increase in the refractive index unit (RIU)), indicating
binding of PEG10K or POEGMA10K onto gold sensor slides (P1
signals in Figure 4a and b, respectively), followed by a slight
decline in the signal due to the removal of unbound polymers
during water rinse of SPR cell under continuous flow. PEG10K
was needed to be injected six times (P1−P6 in Figure 4a),
whereas only three injections were needed for POEGMA10K
(P1−P3 in Figure 4b) to saturate the sensor surface with
polymers. The refractive index unit (RIU) change was 0.070
and 0.016 for PEG10K and POEGMA10K, respectively, possibly
indicating a higher packing of linear PEG10K chains adsorbed on
the surface when compared with the branched POEGMA10K
chains.35 After forming PEG10K or POEGMA10K thin layer on
the gold sensor slides, 20% FBS solution was injected at a flow
rate of 10 μL/min for 10 min followed by water rinse at a flow
rate of 10 μL/min for 10 min. The serum injections and water
rinses were repeated three times, which correspond to the
peaks S1−S3 in Figure 4a,b. The interaction between serum and
PEG10K thin layer was found to be insignificant, as the
sensogram in Figure 4a showed no increase in the baseline
signal upon repeated injections of serum. On the contrary,
there was a significant increase in the baseline signal revealing
the adsorption of serum components by POEGMA10K thin
layer on the sensor slide. Therefore, it was concluded that the
comb-shape POEGMA interacts with serum components, while
PEG does not, supporting the DLS findings described above.
To investigate conformational differences between the
POEGMA and PEG, AFM analyses were performed at liquid
and dry phase (Figures 5 and S3). The AFM images of
POEGMA and PEG taken in water revealed that POEGMA
underwent intrachain self-organization into nanoparticles
depending on the MW while PEG chains exist in a random
conformation regardless of the MW. Lower MW POEGMA
chains, POEGMA10K, displayed self-organization into nano-
particles, while POEGMA20K did not. The average width of a
single POEGMA10K particle was about 17.5 ± 1.7 nm., which
was larger than the Dh observed for the same polymer via DLS.
It should be noted that the tip broadening effect is usually
observed in AFM measurements as a result of the finite size of
the AFM tip with respect to the molecular width. The radius of
curvature of the AFM tip is typically 10−30 nm, which is
almost 10−20× larger than the molecular width. As a result of
this size mismatch, the profile which the tip traces out as it
passes over the molecules is correspondingly broadened. The
broadening was reported to be about 1−5-fold.36,37 Nano-
particles having an apparent diameter of 17.5 ± 1.7 nm were
observed in AFM images of POEGMA10K, which corresponded
to 6-fold of Dh determined by DLS (2.84 ± 1.20 nm),
suggesting the presence of tip broadening effect in AFM
images. In summary, the AFM apparent size was in good accord
with the size of a single polymer chain observed by DLS. The
nanoparticle shape observed in AFM image revealed the
intrachain self-organization behavior of POEGMA10K to adopt
single chain nanoparticle structure.
The self-organization of POEGMA10K chains might arise
from the interfacial energy balance between hydrophobic
poly(methacrylate) backbone and hydrophilic PEG oligomer
chains, and repulsion forces between the PEG oligomer chains.
Degree of polymerization (DP), thus MW, affects the final
molecular conformation of POEGMA since the increasing
number of PEG repeating units increases the solvation effect
and overall repulsion forces between PEG oligomer chains. As a
result, comb-shape POEGMA offers a varying molecular
conformation and intrachain self-organization behavior depend-
ing on the MW of the polymer.
Similar to our findings, Cheng and co-workers reported
conformational change in OEGMA grafted polystyrene as a
function of backbone length and thus amphiphilicity by using
small angle neutron scattering (SANS).38 They found that
polymers with low degrees of polymerization (DP) formed
clusters, whereas increase in DP resulted in disappearance of
clusterization. In agreement with findings of Cheng et al., Liu et
al. reported that conformation of POEGMA changed from
ellipsoidal to cylindrical as a function of increasing backbone
length due to transition from collapsed backbone to extended
backbone as a result of increased solvation effects (H bonding)
and flexibility.39,40
In addition to these studies, POEGMA was also reported to
self-organize into mesoglobules upon heating above its LCST
by Lutz and co-workers.41 However, since the experimental
conditions used by Lutz and co-workers do not translate to
those in this study, the self-organization behavior observed in
POEGMA10K cannot be attributed to mesoglobule formation.
The effect of PEG and POEGMA on cell viability and
membrane permeability was investigated using BEAS-2B
human lung epithelial and A549 human lung carcinoma cell
lines (Figures S5 and S6) by following the protocol described
in the SI. It was found that, even though both PEG and
POEGMA slightly decreased the cell viability of BEAS-2B and
A549 cells in a dose dependent manner, the lowest cell viability
was above 50% in all cases (varying cell lines, polymer
architectures and MW), indicating low cytotoxic effect of both
types of polymers, in agreement with the literature.42
Interestingly, POEGMA20K showed more serious cytotoxicity
than POEGMA10K in the A549, while the result was opposite in
the BEAS-2B cell. This cell-line dependent toxicity profile of
polymers may derive from differences in the cellular processes
and gene expressions of these different cell lines. Additionally,
neither PEG nor POEGMA was found to have an effect on the
Figure 5. AFM micrographs of (a) POEGMA10K, (b) POEGMA20K,
(c) PEG10K, and (d) PEG20K taken in tapping mode in liquid.
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membrane permeability of both cell lines in consistent with the
literature (Figure S5).22,43
The cellular uptake profiles of Oregon Green 488 fluorescent
dye labeled PEG and POEGMA were investigated at varying
temperatures (4 or 37 °C), polymer concentrations (12.5 or 25
μM) and incubation times (1 or 3 h). In these experiments
performed to understand how polymers interact with cells, the
incubation times and polymer doses were chosen to show
possible differences in the kinetics of polymer uptake levels at
as short incubation times as possible to avoid saturation of cells
with polymers. It is known that macromolecular architectures
such as polymers, proteins and polysaccharides at similar MW
range are usually taken up by energy-dependent cellular uptake
mechanisms referred to as endocytosis even though there are
also many exceptions reported in literature.25,44 In accord with
the literature, both PEG and POEGMA were found to be taken
up by both cell lines via energy-dependent mechanisms as the
% cellular uptake (i.e., the ratio of the number of cells that
internalize the polymer to the total number of cells) and uptake
intensity (i.e., total fluorescence intensity divided by the total
number of cells) values observed at 4 °C were found to be
almost completely diminished compared to those at 37 °C (p <
0.01; Figure 6).
Percentages of cellular uptake and uptake intensity of both
types of Oregon Green 488 fluorescent dye labeled polymers
were found to increase significantly in a polymer dose and
incubation time dependent manner at 37 °C in both cell lines
studied (p < 0.05; Figure 7). Significant architecture- and MW-
dependent differences were observed. The POEGMA10K uptake
intensities of both cell lines were found to be higher than or
equal to the PEG10K uptake intensities even though the %
cellular uptake after incubation with POEGMA10K was lower
than or equal to those observed with PEG10K. This result
suggests that POEGMA10K is internalized in equal or higher
quantities per cell than PEG10K. In case of polymers with 20
kDa MW, both cell lines displayed higher uptake intensity and
% cellular uptake after incubation with POEGMA indicating
that POEGMA20K is taken up by higher number of cells in
higher quantities than PEG20K. Overall results show that
POEGMA, regardless of MW, is taken up in higher quantities
by cells compared with the linear counterparts. The higher
uptake intensity of POEGMA (per cell) than PEG was
attributed to the differences in the molecular size, conforma-
tion, chemical structure and protein interactions of polymers
(e.g., compact Dh, amphiphilic structure, and higher serum
protein-binding of POEGMA). On the other hand, the number
of cells that internalize the comb-shape polymers appears to
Figure 6. Energy-dependent cellular uptake of Oregon Green 488 fluorescent dye labeled POEGMAs or PEGs. Cellular uptake profile of Oregon
Green 488 fluorescent dye labeled POEGMAs and PEGs by A549 cells in terms of (a) % cellular uptake and (b) uptake intensity and that by BEAS-
2B cells in terms of (c) % cellular uptake and (d) uptake intensity. The cells were incubated in the presence of Oregon Green 488 fluorescent dye
labeled polymers at a concentration of 25 μM for 3 h at either 4 or 37 °C. Data were analyzed by two-way ANOVA followed by post hoc Dunnett’s
multiple comparison test and plotted as mean ± standard deviation, n = 9; *p < 0.01.
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depend on the MW of the polymer (% cell uptake of
POEGMA10K < PEG10K and POEGMA20K > PEG20K). This
might be due to the varying molecular conformation and self-
organization behavior of comb-shape polymers depending on
the MW, as confirmed by AFM data. The effect of MW of
POEGMA on cellular polymer uptake was more profound in
A549 lung cancer cells. Additionally, higher MW PEG was
found to be uptaken by cells equal to or less than that of lower
MW counterpart in both cell lines studied.
To better understand the cellular uptake profile differences
between POEGMA and PEG mentioned above, the internal-
ization mechanisms of polymers were investigated. Since it is
known that cytoskeleton components play an important role in
multiple cellular activities including endocytosis,25,45 the role of
the two major constituents of cytoskeleton, microtubules and
actin filaments, on the uptake of Oregon Green 488 fluorescent
dye labeled polymers was investigated utilizing nocodazole
(Noc), a microtubule depolymerization inhibitor, and cytocha-
lasin D (CytD), an actin-disrupting agent, respectively, as
transport inhibitors. The cytoskeleton components, micro-
tubule and actin, were found to have a significant role in the
uptake of PEG and POEGMA in both cell lines (p < 0.05;
Figures 8a,b and S11). The uptake of both Oregon Green 488
fluorescent dye labeled PEG and POEGMA by A549 cells was
partially inhibited in the presence of Noc, CytD, or both,
suggesting that both microtubules and actin filaments were
involved in the polymer uptake process. In BEAS-2B cell line,
microtubules had a profound effect on the uptake of both
polymer architectures whereas the role of actin filaments on
Oregon Green 488 fluorescent dye labeled PEG and POEGMA
internalization was found to be statistically insignificant (p >
0.05). Overall, the results showed that the polymer architecture
did not have a differential effect on the polymer internalization
mediated by cytoskeleton inhibitors (vide infra).
The differences in the cellular uptake profile between linear
and comb-shape polymers may be explained by possible
differences in their endocytosis pathways. Clathrin-dependent
(CDE) and caveolae-mediated endocytosis (CME) pathways
play an active role in the polymer uptake by forming clathrin
coated pits with a diameter of 100−150 nm or flask-shape cell
membrane invaginations with a diameter of 50−100 nm,
respectively.46 The inhibition of these pathways was achieved
by treating the cells with chloropromazine (CPZ) and genistein
(GEN) molecules, which are known to inhibit translocation of
clathrin and some adaptor proteins from cell membrane and
pinching off of caveolae from the membrane via inhibition of
Figure 7. Dose- and time-dependent cellular uptake profile of Oregon Green 488 fluorescent dye labeled POEGMAs and PEGs in terms of uptake
intensity (a, b) and % cellular uptake (c, d). Untreated represents cells without any treatment. Data were analyzed by two-way ANOVA followed by
post hoc Dunnett’s multiple comparison test and plotted as mean ± standard deviation, n = 9; *p < 0.05.
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tyrosine kinase, respectively.26 The cellular uptake of Oregon
Green 488 fluorescent dye labeled POEGMAs, regardless of
their molecular weight, decreased in the presence of GEN only
in A549 cell line (p < 0.05) in contrast to the uptake of Oregon
Green 488 fluorescent dye labeled PEGs, which was not
affected by GEN (p > 0.05; Figures 8c,d and S11). CPZ did not
inhibit the polymer uptake by A549 cells regardless of the
polymer architecture (p > 0.05). This result shows that A549
cells differentiate the uptake route of different polymer
architectures, strongly suggesting that caveoale-mediated
endocytosis is one of the essential uptake routes of POEGMA,
but not PEG. This differential response to polymer uptake in
the presence of GEN suggests that PEG and POEGMA are
internalized via different mechanisms in A549 cell line. CPZ, on
the other hand, was found to have no effect on PEG or
POEGMA uptake (p > 0.05) in both cell lines, suggesting that
clathrin-dependent endocytosis is not the major uptake
mechanism for both polymers. In contrast to A549 cell line,
POEGMA internalization was not affected by GEN (p > 0.05)
in BEAS-2B cell line, suggesting that cellular uptake route of
POEGMA significantly depends on the cell type. Cell-line
dependent internalization pathways of polymeric nanoparticles
were also reported in literature supporting our findings.47 To
investigate the role of macropinocytosis, which is a subtype of
endocytosis, on mediating the uptake of polymers, 5-(N-ethyl-
N-isopropyl) amiloride (EIPA), which inhibits macropinocy-
tosis by lowering the submembranous pH, was used. However,
the EIPA concentration values (>50 μM, < 200 μM) in which
macropinocytosis was inhibited, resulted in increased cell
membrane permeability and reduced cell viability preventing us
having a conclusion on macropinocytosis inhibition (Figure
S10). Similar to our findings, the cytotoxic effects of EIPA on
subset of cell lines have also been reported in literature.27
Overall, the results indicate that the CDE and CME are not the
major cellular uptake mechanisms of PEG whereas the cellular
uptake of POEGMA may occur through CME depending on
the cell type. Additionally, higher cellular uptake and
accumulation of POEGMA compared to PEG may also arise
from any other unexamined internalization pathway that might
occur.
The steric hindrance imposed by PEG on the conjugated
biomolecules reduces cellular uptake of the specific cell-
targeting PEGylated systems.9−11 To reveal the possible
differences between POEGMA and PEG in terms of the steric
effects on the conjugated biomolecules, POEGMA10K and
PEG10K were first conjugated to Cy3 fluorescent dye and then a
cyclic pentapeptide c(Arg-Gly-Asp-D-Tyr-Cys) (cRGDyC),
which is known to specifically bind to many types of integrin
proteins, especially to αvβ3,
48 yielding RGD-POEGMA10K-Cy3
and RGD-PEG10K-Cy3 (Figure 9). The degree of RGD labeling
was calculated by following the protocol described in
Experimental Section and given in Table S2.
Figure 8. Cellular uptake profile of Oregon Green 488 fluorescent dye labeled POEGMAs and PEGs in the presence of cytoskeleton (a, b) and
endocytosis inhibitors (c, d). The (−) and (+) controls represent cells without any treatment and cells treated with only the given polymer in the
absence of inhibitors, respectively. Data were analyzed by two-way ANOVA followed by post hoc Dunnett’s multiple comparison test and plotted as
mean ± standard deviation, n = 15; *p < 0.05.
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The uptake intensity of the RGD-POEGMA10K-Cy3
conjugate was found to be almost 3-fold higher compared to
unconjugated POEGMA10K-Cy3 in both cell lines (p < 0.01)
while that of RGD-PEG10K-Cy3 conjugate slightly decreased in
A549 and remained the same in BEAS-2B cell line when
compared with the PEG10K-Cy3 (Figure 10). Similarly, the %
cellular uptake of RGD-PEG10K-Cy3 conjugate remained same
while that of RGD-POEGMA10K-Cy3 conjugate increased in
both cell lines. These uptake profiles were attributed to lower
steric hindrance imposed by POEGMA10K on RGD peptide
compared to that by PEG10K. Due to its more compact
structure and less flexible chains, which were discussed above,
POEGMA10K may not hinder RGD from interacting with
integrin proteins on the cell surface triggering RGD integrin
binding peptide-mediated cellular uptake pathways. The PEG
chains were reported to maintain their flexibility even after
conjugation to proteins49 supporting our findings of higher
steric hindrance imposed by linear PEG architecture compared
to that by comb-shape on the conjugated biomolecules.
Similar to our findings, Ryan et al. reported that conjugation
of POEGMA, which had 23 ethylene glycol unit-long pendant
chains, to a small peptide, salmon calcitonin, did not result in a
quite significant reduction in bioactivity.42 Zarafshani and co-
workers, on the other hand, reported that trypsin-POEGMA
conjugate showed higher activity than native trypsin,50 which
was later attributed to hydrophobicity of POEGMA backbone,
which promotes hydrophobic interactions with local environ-
ment.51 Therefore, it is possible that the hydrophobicity of
backbone may be one of the parameters having a role on the
lower steric hindrance impart on RGD by POEGMA in
addition to its more compact structure and less flexible chains
than PEG.
Interestingly, Gauthier and co-workers reported that the
conformation of POEGMA, either ellipsoidal shape with
collapsed backbone or cylindrical shape with extended
backbone depending on the backbone length thus MW, on
the surface of α-chymotrypsin affected its bioactivity due to
varying levels penetration of the substrate at different
conformations of POEGMA.39,40 They also reported that
conjugation of POEGMA having ellipsoidal shape due to
shorter backbone to asparaginase (ASNase) yielded higher
bioactivity and lower immunogenicity than that of having
cylindrical shape due to longer backbone.40 Similarly, the steric
hindrance imposed by POEGMA on RGD in this study may be
a function of POEGMA backbone length and, thus, MW.
■ CONCLUSION
Collectively, our findings establish a better understanding of the
utility of comb-shape POEGMA as a stealth alternative to PEG
in pharmaceutical applications. These significant findings on
stealth properties, molecular conformation and in vitro cell
interactions of POEGMA suggest the presence of inherent
differences between comb-shape and linear architectures of
PEG. Future plans include establishing further conformational
analysis of POEGMA to tune its in vivo properties.
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effect of cytoskeleton inhibitors (Noc and CytD) and
endocytosis inhibitors (chlorpromazine, genistein and
EIPA) on cell viability, the inhibition profiles of CDE,
CME, and macropinocytosis pathways at various
concentrations of inhibitors, POEGMA and PEG uptake
intensities in the presence of cytoskeleton and
endocytosis inhibitors (PDF).
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(34) Lutz, J.-F.; Akdemir, Ö.; Hoth, A. Point by Point Comparison of
Two Thermosensitive Polymers Exhibiting a Similar LCST: Is the Age
of Poly(NIPAM) Over? J. Am. Chem. Soc. 2006, 128, 13046−13047.
(35) Yeh, P-Y. J.; Kainthan, R. K.; Zou, Y.; Chiao, M.; Kizhakkedathu,
J. N. Self-Assembled Monothiol-Terminated Hyperbranched Poly-
glycerols on a Gold Surface: A Comparative Study on the Structure,
Morphology, and Protein Adsorption Characteristics with Linear
Poly(ethylene glycol)s. Langmuir 2008, 24, 4907−4916.
(36) Raposo, M.; Ferreira, Q.; Ribeiro, P. In Modern Research and
Educational Topics in Microscopy: A Guide for Atomic Force Microscopy
Analysis of Soft Condensed Matter; Meńdez-Vilas, A., Díaz, J., Eds.;
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